Catalyst Wire Dossier Catalyst Wire Dossier

Immunomodulatory mesenchymal stem cells

mesenchymal stem cells · ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunomodulatory mesenchymal stem cells, covering 2024-09-05 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation [Phase 1]

See pricing